Pharmaceutical Business review

HCL Technologies to deploy Oracle Siebel CTMS in Novotech

Utilising CTMS as a centralised repository for all investigators, clinical trial sponsors can collect and track all relevant information about their investigators, from personal profiles to disease specialties, from past trial experiences to current trial performance.

Oracle’s Siebel CTMS is expected to offer clinical trial management services to Novotech across Asia Pacific.

HCL claims that the Siebel CTMS gives up-to-date information to Novotech clients regarding progress of the project.

HCL Technologies APAC & MEA executive vice president Virender Aggarwal quoted by Business Standard as saying that HCL has an excellent track record working with pharmaceutical companies globally and their partnership with Novotech further fortifies HCL’s life sciences presence in Australia.

"With more than 2000 professionals servicing the ANZ region and a broad set of global, multi-vendor capabilities HCL will help Novotech to become more agile in today’s competitive environment," Aggarwal said.